Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 389-394

  Pompili, Maurizio ^a,b   Gibiino, Sara ^c   Innamorati, Marco ^a   Serafini, Gianluca ^a   Del Casale, Antonio ^a   De Risio, Luisa ^a   Palermo, Mario ^a   Montebovi, Franco ^a   Campi, Sandra ^a   De Luca, Vincenzo ^d   Sher, Leo ^e   Tatarelli, Roberto ^a   Biondi, Massimo ^g   Duval, Fabrice ^f   Serretti, Alessandro ^c   Girardi, Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b MCLEAN HOSPITAL   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Centre Hospitalier de Rouffach   (France)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Attempted suicide; Biological predictors; Depression; Mood disorder; Thyroid hormones

Indexed keywords

LIOTHYRONINE; PROLACTIN; THYROID HORMONE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SEX DIFFERENCE; SUICIDE ATTEMPT; THYROID HORMONE BLOOD LEVEL;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PROLACTIN; RISK FACTORS; SUICIDE, ATTEMPTED; TRIIODOTHYRONINE;

EID: 84872372807     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.05.010     Document Type: Article

References (30)

1. Alkemade A., Unmehopa U.A., Brouwer J.P., Hoogendijk W.J., Wiersinga W.M., Swaab D.F., Fliers E. Decreased thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus of patients with major depression. Molecular Psychiatry 2003, 8:838-839.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1987, American Psychiatric Association, Washington, DC. 3rd edition revised - DSM-III-R.
3. Amorim P., Lecrubier Y., Weiller E., Hergueta T., Sheehan D. DSM-III-R psychotic disorders: Procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. European Psychiatry 1998, 13:26-34.
4. Banki C.M., Arato M., Papp Z., Kurcz M. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. Journal of Affective Disorders 1984, 6:341-350.
5. Beautrais A.L., Joyce P.R., Mulder R.T., Fergusson D.M., Deavoll B.J., Nightingale S.K. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. American Journal of Psychiatry 1996, 153:1009-1014.
6. Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 1995, 57:289-300.
7. Cavanagh J.T., Carson A.J., Sharpe M., Lawrie S.M. Psychological autopsy studies of suicide: a systematic review. Psychological Medicine 2003, 33:395-405.
8. Correa H., Duval F., Mokrani M., Bailey P., Tremeau F., Staner L., Diep T.S., Hode Y., Crocq M.A., Macher J.P. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Research 2000, 93:189-199.
9. Correa H., Duval F., Mokrani M.C., Bailey P., Tremeau F., Staner L., Diep T.S., Crocq M.A., Macher J.P. Serotonergic function and suicidal behavior in schizophrenia. Schizophrenia Research 2002, 56:75-85.
10. Corrigan M.H., Gillette G.M., Quade D., Garbutt J.C. Panic, suicide, and agitation: independent correlates of the TSH response to TRH in depression. Biological Psychiatry 1992, 31:984-992.
11. Dinan T.G. Glucocorticoids and the genesis of depressive illness. A psychobiological model. The British Journal of Psychiatry 1994, 164:365-371.
12. Duval F., Macher J.P., Mokrani M.C. Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Archives of General Psychiatry 1990, 47:443-448.
13. Duval F., Mokrani M.C., Crocq M.A., Jautz M., Bailey P., Diep T.S., Macher J.P. Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Archives of General Psychiatry 1996, 53:833-840.
14. Duval F., Mokrani M.C., Bailey P., Correa H., Diep T.S., Crocq M.A., Macher J.P. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology 1999, 24:695-712.
15. Duval F., Mokrani M.C., Monreal J., Weiss T., Fattah S., Hamel B., Macher J.P. Interaction between the serotonergic system and HPA and HPT axes in major depression: implications for pathogenesis of suicidal behavior. Dialogues in Clinical Neurosciences 2002, 4:417-425.
16. Duval F., Mokrani M.C., Lopera F.G., Diep T.S., Rabia H., Fattah S. Thyroid axis activity and suicidal behavior in depressed patients. Psychoneuroendocrinology 2010, 35:1045-1054.
17. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
18. Joffe R.T., Sokolov S.T. Thyroid hormones, the brain, and affective disorders. Critical Reviews in Neurobiology 1994, 8:45-63.
19. Jokinen J., Samuelsson M., Nordstrom A.L., Nordstrom P. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters. Journal of Affective Disorders 2008, 111:119-124.
20. Kavoussi R.J., Coccaro E.F., Klar H., Lesser J., Siever L.J. The TRH-stimulation test in DSM-III personality disorder. Biological Psychiatry 1993, 34:234-239.
21. Linkowski P., Van Wettere J.P., Kerkhofs M., Brauman H., Mendlewicz J. Thyrotrophin response to thyreostimulin in affectively ill women relationship to suicidal behaviour. British Journal of Psychiatry 1983, 143:401-405.
22. Linkowski P., Van Wettere J.P., Kerkhofs M., Gregoire F., Brauman H., Mendlewicz J. Violent suicidal behavior and the thyrotropin-releasing hormone-thyroid-stimulating hormone test: a clinical outcome study. Neuropsychobiology 1984, 12:19-22.
23. Mann J.J., Currier D. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Archives of Suicide Research 2007, 11:3-16.
24. Pfohl B., Blum N., Zimmerman M. Structured Interview for DSM-IV Personality: SIDP-IV 1997, American Psychiatric Publishing, Washington, DC.
25. Pompili M. Exploring the phenomenology of suicide. Suicide & Life-Threatening Behavior 2010, 40:234-244.
26. Pompili M. From bench to bedside in the prevention of suicide: a never-ending back and forth journey. Crisis 2010, 31:59-61.
27. Pompili M., Serafini G., Innamorati M., Moller-Leimkuhler A.M., Giupponi G., Girardi P., Tatarelli R., Lester D. The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention 2010.
28. Rich C.L. Endocrinology and suicide. Suicide & Life-Threatening Behavior 1986, 16:301-311.
29. Silverman M.M., Berman A.L., Sanddal N.D., O'Carroll P., Joiner, T.E.W. Rebuilding the tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors. Part 1: background, rationale, and methodology. Suicide & Life-Threatening Behavior 2007, 37:248-263.
30. Silverman M.M., Berman A.L., Sanddal N.D., O'Carroll P., Joiner, T.E.W. Rebuilding the tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors. Part 2: suicide-related ideations, communications, and behaviors. Suicide & Life-Threatening Behavior 2007, 37:264-277.